The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Support COVID-19 Research

Publication

< Back to Publications Listing

Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence


Author(s):

Benjamin Varco-Merth, Morgan Chaunzwa, Derick M. Duell, Alejandra Marenco, William Goodwin, Rachel Dannay, Michael Nekorchuk, Danica Shao, Kathleen Busman-Sahay, Christine M. Fennessey, Lorna Silipino, Michael Hull, William J. Bosche, Randy Fast, Kelli Oswald, Rebecca Shoemaker, Rachele Bochart, Rhonda MacAllister, Caralyn S. Labriola, Jeremy V. Smedley, Michael K. Axthelm, Miles P. Davenport, Paul T. Edlefsen, Jacob D. Estes, Brandon F. Keele, Jeffrey D. Lifson, Sharon R. Lewin, Louis J. Picker, Afam A. Okoye

Details:

PLoS Pathogens, Volume 20, Issue 8, 2024-08-01, Article number e1012496

Article Link: Click here

Affiliations:

  • Fred Hutchinson Cancer Center
  • The Peter Doherty Institute for Infection and Immunity
  • Leidos Inc.
  • The Kirby Institute
  • Monash University
  • Oregon Health & Science University
  • Oregon National Primate Research Center
  • Royal Melbourne Hospital

Contact Us

792 Elizabeth Street
Melbourne, 3000
Get Directions

doherty-reception@unimelb.edu.au
+61 3 9035 3555
Contact Us

Keep informed

Subscribe for the latest news, events and research

We acknowledge the Wurundjeri people of the Kulin Nation as the traditional custodians of the land where our Institute stands.

We are committed to collaboration with Aboriginal and Torres Strait Islander communities to reduce the unacceptable burden of infectious disease. We are committed to training the next generation of exceptional Indigenous leaders in infection and immunity.

Copyright The Peter Doherty Institute for Infection and Immunity
Privacy Policy | Intranet | Site by Lemonade